Q4 Pharma & Biotech News: The Highlights

The last quarter of 2016 was certainly not short of activity with a £84 million pharma fine issued in regards to drug pricings, an investigation into a suspected supply chain breach and numerous therapeutic approvals. Pfizer to challenge £84 million fine decision over 2600% drug price increase The